CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies
Open Access
- 1 March 2014
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 20 (3), 382-386
- https://doi.org/10.1016/j.bbmt.2013.11.034
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor Induced Acute and Chronic Graft-Versus-Host DiseaseTransplantation, 2010
- Anemia Associated with Impaired Erythropoietin Secretion after Allogeneic Stem Cell Transplantation: Incidence, Risk Factors, and Response to TreatmentTransplantation and Cellular Therapy, 2008
- Fludarabine-Based Conditioning Secures Engraftment of Second Hematopoietic Stem Cell Allografts (HSCT) in the Treatment of Initial Graft FailureTransplantation and Cellular Therapy, 2007
- Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantationBone Marrow Transplantation, 2007
- CD34+-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantationCytotherapy, 2006
- CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failureBone Marrow Transplantation, 2005
- Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemiaBritish Journal of Haematology, 2000
- CD34+ immunoselected cells for poor graft function following allogeneic BMTCytotherapy, 2000
- Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.Acta Haematologica, 2000
- Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantationBone Marrow Transplantation, 1998